Medications

Metoprolol: An old drug with unique cardioprotective properties

A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has been in use for more ...

Diseases, Conditions, Syndromes

COVID-19 cardiac involvement on the rise

In the early stages of the COVID-19 pandemic, the disease was recognized as a respiratory virus. Research is showing that the SARS-CoV-2 virus is causing more significant cardiac issues than initially thought.

Neuroscience

Taking the STING out of MND

Melbourne researchers are working towards a potential treatment to slow the progression of motor neuron disease (MND), offering hope to people with this debilitating and incurable illness.

Medical research

Tumor progression depends on the tumor microenvironment

Tumor cells constantly interact with the cellular environment they live in, affecting tumor progression and metastasis. In a new study, researchers from Tokyo Medical and Dental University (TMDU) and Niigata University discovered ...

Medical research

Cell therapy designed to treat inflammatory bowel disease

The UPV/EHU's NanoBioCel research group is developing systems that enable cells to be used as drugs. Cell therapy raises hopes for treating those diseases for which there are as yet no effective pharmacological solutions. ...

Immunology

Steering the immune system with liposomes

Liposomes—nano-sized spheres composed of fatty molecules—are very promising for vaccination. Bio-pharmaceutical scientist Naomi Benne discovered that the immune response in animal models can be steered by varying the ...

page 2 from 92